[1] LI C Y, WU X Y, TONG J B, et al. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy . Stem Cell Res Ther, 2015, 6(1):55.
[2] FRESE L, DIJKMAN P E, HOERSTRUP S P. Adipose tissue-derived stem cells in regenerative medicine . Transfus Med Hemoth, 2016, 43(4):268-274.
[3] JACKSON W M, ALEXANDER P G, BULKEN-HOOVER J D, et al. Mesenchymal progenitor cells derived from traumatized muscle enhance neurite growth . J Tissue Eng Regener Med, 2013, 7(6):443-451.
[4] BEERAVOLU N, MCKEE C, ALAMRI A, et al. Isolation and characterization of mesenchymal stromal cells from human umbilical cord and fetal placenta . J Visual Exp, 2017,(122):e55224.
[5] KERN S, EICHLER H, STOEVE J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue . Stem Cells, 2006, 24(5):1294-1301.
[6] PERRY B C, ZHOU D, WU X H, et al. Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use . Tissue Eng, Part C, 2008, 14(2):149-156.
[7] YU B, ZHANG X M, LI X R. Exosomes derived from mesenchymal stem cells . Int J Mol Sci, 2014, 15(3):4142-4157.
[8] SAN LUCAS F A, ALLENSON K, BERNARD V, et al. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes . Ann Oncol, 2016, 27(4):635-641.
[9] JOHNSEN K B, GUDBERGSSON J M, SKOV M N, et al. A comprehensive overview of exosomes as drug delivery vehicles-Endogenous nanocarriers for targeted cancer therapy . Biochim Biophys Acta, Rev Cancer, 2014, 1846(1):75-87.
[10] LAI R C, ARSLAN F, LEE M M, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury . Stem Cell Res, 2010, 4(3):214-222.
[11] LAI R C, TAN S S, TEH B J, et al. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome . Int J Proteomics, 2012, 2012: 971907.
[12] STOLK M, SEIFERT M. Protein contaminations impact quantification and functional analysis of extracellular vesicle preparations from mesenchymal stromal cells . J Stem Cells Regen Med, 2015, 11(2):44-47.
[13] LOU G H, CHEN Z, ZHENG M, et al. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases . Exp Mol Med, 2017, 49(6):e346.
[14] LAI R C, YEO R W Y, TAN K H, et al. Exosomes for drug delivery-a novel application for the mesenchymal stem cell . Biotechnol Adv, 2013, 31(5):543-551.
[15] LU W, YANG R Q, LING W. Research progress of exosomes . Chem Life(生命的化学), 2013, 33(4):438-442.
[16] RAPOSO G, STOORVOGEL W. Extracellular vesicles: Exosomes, microvesicles, and friends . J Cell Biol, 2013, 200(4):373-383.
[17] SHAMILI F H, BAYEGI H R, SALMASI Z, et al. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model . Int J Pharm, 2018, 549(1-2):218-229.
[18] TIAN Y H, LI S P, SONG J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy . Biomaterials, 2014, 35(7):2383-2390.
[19] JOHNSEN K B, GUDBERGSSON J M, SKOV M N, et al. A comprehensive overview of exosomes as drug delivery vehicles-Endogenous nanocarriers for targeted cancer therapy . Biochim Biophys Acta, Rev Cancer, 2014, 1846(1):75-87.
[20] HOOD J L, SCOTT M J, WICKLINE S A. Maximizing exosome colloidal stability following electroporation . Anal Biochem, 2014, 448: 41-49.
[21] WAHLGREN J, KARLSON T D L, BRISSLERT M, et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes . Nucleic Acids Res, 2012, 40(17):e130.
[22] YIM N, CHOI C. Extracellular vesicles as novel carrier for therapeutic molecules . Bmb Rep, 2016, 49(11):585-586.
[23] CUI G H, WU J, MOU F F, et al. Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice . Faseb J, 2018, 32(2):654-668.
[24] SHTAM T A, KOVALEV R A, VARFOLOMEEVA E Y, et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro . Cell Commun Signal, 2013, 11: 88.
[25] MIZRAK A, BOLUKBASI M F, OZDENER G B, et al. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth . Mol Ther, 2013, 21(1):101-108.
[26] HE J G, LI H R, HAN J X, et al. GATA-4-expressing mouse bone marrow mesenchymal stem cells improve cardiac function after myocardial infarction via secreted exosomes . Sci Rep, 2018, 8(1):9047.
[27] PASCUCCI L, COCCÈ V, BONOMI A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery . J Controlled Release, 2014, 192(1-2): 262-270.
[28] SUN D M, ZHUANG X Y, XIANG X Y, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes . Mol Ther, 2010, 18(9):1606-1614.
[29] TIAN Y H, LI S P, SONG J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy . Biomaterials, 2014, 35(7):2383-2390.
[30] CUI X, HE Z, LIANG Z, et al. Exosomes from adipose-derived mesenchymal stem cells protect the myocardium against ischemia/reperfusion injury through Wnt/β-catenin signaling pathway . J Cardiov Pharmacol, 2017, 70(4):225-231.
[31] LIU L, JIN X, HU C F, et al. Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt pathways . Cell Physiol Biochem, 2017, 43(1):52-68.
[32] HE H S, LU Y, QI J P, et al. Adapting liposomes for oral drug delivery . Acta Pharm Sin B(药学学报英文版), 2019, 9(1):36-48.
[33] ZHOU J, ZHAO W Y, MA X, et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer . Biomaterials, 2013, 34(14):3626-3638.
[34] SERCOMBE L, VEERATI T, MOHEIMANI F, et al. Advances and challenges of liposome assisted drug delivery . Front Pharmacol, 2015, 6: 286.
[35] CHEN K H, CHEN C H, WALLACE C G, et al. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke . Oncotarget, 2016, 7(46):74537-74556.
[36] LONG Q, UPADHYA D, HATTIANGADY B, et al. Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus . Proc Natl Acad Sci USA, 2017, 114(17):3536-3545.
[37] ALTANEROVA U, JAKUBECHOVA J, BENEJOVA K, et al. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes . Int J Cancer, 2019, 144(4):897-908.
[38] LI H, LIU D, LI C, et al. Exosomes secreted from mutant-HIF-1α-modified bone-marrow-derived mesenchymal stem cells attenuate early steroid-induced avascular necrosis of femoral head in rabbit . Cell Biol Int, 2017, 41(12):1379-1390.
[39] WANG X, CHEN Y H, ZHAO Z N, et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction . J Am Heart Assoc, 2018, 7(15):e8737.
[40] CHEN T S, ARSLAN F, YIN Y, et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs . J Transl Med, 2011, 9(1):47.
[41] YEO R W Y, LAI R C, ZHANG B, et al. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery . Adv Drug Deliv Rev, 2013, 65(3):336-341.
[42] LU M, XING H N, XUN Z, et al. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems . Eur J Pharm Sci, 2018, 121: 34-46.
[43] TIAN T, ZHANG H X, HE C P, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy . Biomaterials, 2018, 150: 137-149.
[44] ARMSTRONG J P K, HOLME M N, STEVENS M M. Re-Engineering extracellular vesicles as smart nanoscale therapeutics . Acs Nano, 2017, 11(1):69-83.
[45] ARSLAN F, LAI R C, SMEETS M B, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury . Stem Cell Res, 2013, 10(3):301-312.
[46] ZHANG Z W, YANG J J, YAN W Y, et al. Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair . J Am Heart Assoc, 2016, 5(1):e2856.
[47] MA T, CHEN Y Q, CHEN Y H, et al. MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction . Stem Cells Int, 2018, 2018: 3290372.
[48] XIAO C C, WANG K, XU Y C, et al. Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b . Circ Res, 2018, 123(5):564-578.
[49] FANG L, SHI X F, SUN H Y, et al. Effects of exosomes derived from miR-486 gene modified umbilical cord mesenchymal stem cells on biological characteristics of rat cardiomyocytes . J Exp Hematol(中国实验血液学杂志), 2018, 26(5):1531-1537.
[50] ZHU J Y, LU K, ZHANG N, et al. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way . Artif Cells, Nanomed, Biotechnol, 2018, 46(8):1659-1670.
[51] ZHU L P, TIAN T, WANG J Y, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction . Theranostics, 2018, 8(22):6163-6177.
[52] WANG Y, ZHAO R Z, LIU D B, et al. Exosomes derived from miR-214-enriched bone marrow-derived mesenchymal stem cells regulate oxidative damage in cardiac stem cells by targeting CaMKII . Oxid Med Cell Longev, 2018, 2018: 4971261.
[53] XIN H Q, LI Y, CUI Y S, et al. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats . J Cereb Blood Flow Metab, 2013, 33(11):1711-1715.
[54] HE G, ZHANG W, MA Y, et al. Mesenchymal stem cells-derived exosomes ameliorate blue light stimulation in retinal pigment epithelium cells and retinal laser injury by VEGF-dependent mechanism . Int J Ophthalmol, 2018, 11(4):559-566.
[55] XIN H Q, KATAKOWSKI M, WANG F J, et al. MicroRNA-17-92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke, 2017, 48(3):747-753.
[56] XIN H Q, WANG F J, LI Y F, et al. Secondary release of exosomes from astrocytes contributes to the increase in neural plasticity and improvement of functional recovery after stroke in rats treated with exosomes harvested from MicroRNA 133b-overexpressing multipotent mesenchymal stromal cells . Cell Transplant, 2017, 26(2):243-257.
[57] MEAD B, TOMAREV S. Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-dependent mechanisms . Stem Cells Transl Med, 2017, 6(4):1273-1285.
[58] YU D D, WU Y, SHEN H Y, et al. Exosomes in development, metastasis and drug resistance of breast cancer . Cancer Sci, 2015, 106(8):959-964.
[59] LEE J K, PARK S R, JUNG B K, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells . PLoS One, 2013, 8(12):e84256.
[60] LIN R Z, WANG S H, ZHAO R C. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model . Mol Cell Biochem, 2013, 383(1-2):13-20.
[61] BLISS S A, SINHA G, SANDIFORD O A, et al. Mesenchymal stem cell-derived exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrow . Cancer Res, 2016, 76(19):5832-5844.
[62] NASERI Z, KAZEMI OSKUEE R, JAAFARI M R, et al. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo . Int J Nanomed, 2018, 13: 7727-7747.
[63] PAKRAVAN K, BABASHAH S, SADEGHIZADEH M, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells . Cell Oncol, 2017, 40(5):457-470.
[64] KALIMUTHU S, GANGADARAN P, RAJENDRAN R L, et al. A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy . Front Pharmacol, 2018, 9: 1116.
[65] REZA A M M T, CHOI Y J, YASUDA H, et al. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells . Sci Rep, 2016, 6(1):38498.
[66] MUNOZ J L, BLISS S A, GRECO S J, et al. Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity . Mol Ther--Nucleic Acids, 2013, 2: e126.
[67] SHARIF S, GHAHREMANI M H, SOLEIMANI M. Delivery of exogenous miR-124 to glioblastoma multiform cells by wharton‘s jelly mesenchymal stem cells decreases cell proliferation and migration, and confers chemosensitivity . Stem Cell Rev Rep, 2018, 14(2):236-246.
[68] HUANG F, YAO Y L, WU J H, et al. Effect of mesenchymal stem cell derived exosomes carrying PDGFD on lung cancer . Int J Clin Exp Pathol, 2017, 10(1): 224-232.
[69] LI H D, YANG C, SHI Y J, et al. Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress sorafenib resistance in hepatocellular carcinoma . J Nanobiotechnol, 2018, 16(1):103.
[70] ZHANG S, CHU W C, LAI R C, et al. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration . Osteoarthr Cartilage, 2016, 24(12):2135-2140.
[71] JIANG L R, ZHANG S Q, HU H Z, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages . Biochem Biophys Res Commun, 2019, 508(3):735-741.
[72] JIANG W Q, TAN Y W, CAI M J, et al. Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect . Stem Cells Int, 2018, 2018: 6079642.
[73] CHEN L, LU F B, CHEN D Z, et al. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis . Mol Immunol, 2018, 93: 38-46.
[74] JIA H Y, LIU W Z, ZHANG B, et al. HucMSC exosomes-delivered 14-3-3ζ enhanced autophagy via modulation of ATG16L in preventing cisplatin-induced acute kidney injury . Am J Transl Res, 2018, 10(1):101-113.
[75] ZHOU Y, XU H T, XU W R, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro . Stem Cell Res Ther, 2013, 4(2):34.
[76] KIM M, YUN H W, PARK D Y, et al. Three-dimensional spheroid culture increases exosome secretion from mesenchymal stem cells . Tissue Eng Regener Med, 2018, 15(4):427-436.
[77] HARASZTI R A, MILLER R, STOPPATO M, et al. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity . Mol Ther, 2018, 26(12):2838-2847.